Search Legislation

Advanced Search

The Human Medicines (Amendment etc.) (EU Exit) (No. 2) Regulations 2021

Help about what version

What Version

  • Draft legislation
Help about opening options

Opening Options

Draft Legislation:

This is a draft item of legislation and has not yet been made as a UK Statutory Instrument.

  1. Introductory Text

  2. PART 1 General

    1. 1.Citation and commencement

    2. 2.Amendment of the Human Medicines Regulations 2012

    3. 3.Amendment of the Medicines (Products for Human Use) (Fees) Regulations 2016

    4. 4.Amendment of the Medicines for Human Use (Clinical Trials) Regulations 2004

  3. PART 2 Amendment of the Human Medicines Regulations 2012

    1. 5.Amendment of regulation 8 (general interpretation)

    2. 6.Amendment of regulation 43 (obligations of licence holder)

    3. 7.Amendment of regulation 45A (brokering in medicinal products)

    4. 8.Amendment of regulation 49 (application for grant of UK marketing authorisation or parallel import licence)

    5. 9.Amendment of regulation 58 (consideration of application)

    6. 10.Amendment of regulation 60A (condition as to the submitting of samples and other information to the appropriate authority)

    7. 11.Amendment of regulation 60B (submitting of samples and other information: EU marketing authorisations)

    8. 12.Amendment of regulation 167 (supply to fulfil special patient needs)

    9. 13.Amendment of regulation 182 (obligation on holder to operate pharmacovigilance system)

    10. 14.Amendment of regulation 188 (reporting obligations on holders)

    11. 15.Amendment of regulation 193 (harmonisation of PSUR frequency or date of submission)

    12. 16.Amendment of regulation 199 (submission of draft study protocols for required studies)

    13. 17.Amendment of regulation 200 (amendment to study protocols for required studies)

    14. 18.Amendment of regulation 201 (submission and evaluation of final study reports for required studies)

    15. 19.Amendment of regulation 202A (licensing authority power in relation to medicinal products subject to additional monitoring)

    16. 20.Amendment of Schedule 8 (material to accompany an application for a UK marketing authorisation)

    17. 21.Amendment of Schedule 11 (advice and representations)

    18. 22.Amendment of Schedule 27 (package leaflets)

    19. 23.Amendment of Schedule 33A (transitional provisions)

  4. PART 3 Amendment of the Medicines (Products for Human Use) (Fees) Regulations 2016

    1. 24.Amendment of regulation 19F (fee for testing of samples by the appropriate authority)

    2. 25.Amendment of regulation 27A (fee for renewals of a marketing authorisation)

    3. 26.Amendment of regulation 46 (fees for applications for certificates)

    4. 27.Amendment of Schedule 2 (capital fees for applications for, and variations to, marketing authorisations, licences, registrations and certificates)

    5. 28.Amendment of Schedule 5 (fees for certificates of registration)

  5. PART 4 Amendment of the Medicines for Human Use (Clinical Trials) Regulations 2004

    1. 29.Amendment of regulation 57 (functions in relation to good clinical practice)

  6. Signature

  7. Explanatory Note

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Draft Explanatory Memorandum

Draft Explanatory Memorandum sets out a brief statement of the purpose of a Draft Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Draft Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as draft version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources

The data on this page is available in the alternative data formats listed: